Decreased PADI4 mRNA Association with Global Hypomethylation in Hepatocellular Carcinoma During HBV Exposure

详细信息    查看全文

• 作者：Changsong Zhang (1) (2) (3)
  Lieying Fan (2)
  Tingting Fan (2)
  Dong Wu (1)
  Lu Gao (1)
  Yang Ling (3)
  Jing Zhu (3)
  Rong Li (1)
  Lixin Wei (1)
  
• 关键词：Peptidylarginine deiminase type 4 ; Hepatocellular carcinoma ; Line ; 1 ; Methylation
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2013
• 出版时间：March 2013
• 年：2013
• 卷：65
• 期：2
• 页码：187-195
• 全文大小：711KB
• 参考文献：1. Wang, Y., Wysocka, J., Perlin, J. R., Leonelli, L., Allis, C. D., et al. (2004). Linking covalent histone modifications to epigenetics: The rigidity and plasticity of the marks. / Cold Spring Harbor Symposia on Quantitative Biology, / 69, 161-69. CrossRef
  2. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A., & Buzas, E. I. (2006). Citrullination: A posttranslational modification in health and disease. / International Journal of Biochemistry & Cell Biology, / 38, 1662-677. CrossRef
  3. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., & Pruijn, G. J. (2003). PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. / BioEssays, / 25, 1106-118. CrossRef
  4. Nakashima, K., Hagiwara, T., & Yamada, M. (2002). Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. / Journal of Biological Chemistry, / 277, 49562-9568. CrossRef
  5. Arita, K., Hashimoto, H., Shimizu, T., Nakashima, K., Yamada, M., et al. (2004). Structural basis for Ca(2+)-induced activation of human PAD4. / Nature Structural & Molecular Biology, / 11, 777-83. CrossRef
  6. Wang, Y., Wysocka, J., Sayegh, J., Lee, Y. H., Perlin, J. R., et al. (2004). Human PAD4 regulates histone arginine methylation levels via demethylimination. / Science, / 306, 279-83. CrossRef
  7. Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., et al. (2004). Histone deimination antagonizes arginine methylation. / Cell, / 118, 545-53. CrossRef
  8. Balint, B. L., Szanto, A., Madi, A., Bauer, U. M., Gabor, P., et al. (2005). Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. / Molecular and Cellular Biology, / 25, 5648-663. CrossRef
  9. Raijmakers, R., Zendman, A. J., Egberts, W. V., Vossenaar, E. R., Raats, J., et al. (2007). Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. / Journal of Molecular Biology, / 367, 1118-129. CrossRef
  10. Anzilotti, C., Pratesi, F., Tommasi, C., & Migliorini, P. (2010). Peptidylarginine deiminase 4 and citrullination in health and disease. / Autoimmunity Reviews, / 9, 158-60. CrossRef
  11. Jones, J. E., Causey, C. P., Knuckley, B., Slack-Noyes, J. L., & Thompson, P. R. (2009). Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. / Current Opinion in Drug Discovery & Development, / 12, 616-27.
  12. Slack, J. L., Jones, L. E., Bhatia, M. M., & Thompson, P. R. (2011). Autodeimination of protein arginine deiminase 4 alters protein–protein interactions but not activity. / Biochemistry, / 50, 3997-010. CrossRef
  13. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., et al. (2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. / Nature Genetics, / 34, 395-02. CrossRef
  14. Chang, X., & Han, J. (2006). Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. / Molecular Carcinogenesis, / 45, 183-96. CrossRef
  15. Wang, L., Chang, X., Yuan, G., Zhao, Y., & Wang, P. (2010). Expression of peptidylarginine deiminase type 4 in ovarian tumors. / International Journal of Biological Sciences, / 6, 454-64. CrossRef
  16. Chang, X., Han, J., Pang, L., Zhao, Y., Yang, Y., et al. (2009). Increased PADI4 expression in blood and tissues of patients with malignant tumors. / BMC Cancer, / 9, 40. CrossRef
  17. Chang, X., & Fang, K. (2010). PADI4 and tumourigenesis. / Cancer Cell International, / 10, 7. CrossRef
  18. Li, P., Yao, H., Zhang, Z., Li, M., Luo, Y., et al. (2008). Regulation of p53 target gene expression by peptidylarginine deiminase 4. / Molecular and Cellular Biology, / 28, 4745-758. CrossRef
  19. Li, P., Wang, D., Yao, H., Doret, P., Hao, G., et al. (2010). Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. / Oncogene, / 29, 3153-162. CrossRef
  20. Liu, G. Y., Liao, Y. F., Chang, W. H., Liu, C. C., Hsieh, M. C., et al. (2006). Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells. / Apoptosis, / 11, 183-96. CrossRef
  21. Zhang, C., Xu, Y., Zhao, J., Fan, L., Jiang, G., et al. (2011). Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. / Annals of Surgical Oncology, / 18, 2373-380. CrossRef
  22. Aporntewan, C., Phokaew, C., Piriyapongsa, J., Ngamphiw, C., Ittiwut, C., et al. (2011). Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. / PLoS ONE, / 6, e17934. CrossRef
  23. Edmondson, H. A., & Steiner, P. E. (1954). Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. / Cancer, / 7, 462-03. CrossRef
  24. Gao, Q., Wang, X. Y., Zhou, J., & Fan, J. (2011). Cell line misidentification: The case of the Chang liver cell line. / Hepatology, / 54, 1894-895. CrossRef
  25. Fan, L. Y., Wang, W. J., Wang, Q., Zong, M., Yang, L., et al. (2008). A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. / Tissue Antigens, / 72, 469-73. CrossRef
  26. Thompson, P. R., & Fast, W. (2006). Histone citrullination by protein arginine deiminase: Is arginine methylation a green light or a roadblock? / ACS Chemical Biology, / 1, 433-41. CrossRef
  27. Herceg, Z., & Paliwal, A. (2011). Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome. / Mutation Research, / 727, 55-1. CrossRef
  28. Sceusi, E. L., Loose, D. S., & Wray, C. J. (2011). Clinical implications of DNA methylation in hepatocellular carcinoma. / HPB (Oxford), / 13, 369-76. CrossRef
  29. Hatziapostolou, M., & Iliopoulos, D. (2011). Epigenetic aberrations during oncogenesis. / Cellular and Molecular Life Sciences, / 68, 1681-702. CrossRef
  30. Han, J. S., Szak, S. T., & Boeke, J. D. (2004). Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. / Nature, / 429, 268-74. CrossRef
  31. Vivekanandan, P., Daniel, H. D., Kannangai, R., Martinez-Murillo, F., & Torbenson, M. (2010). Hepatitis B virus replication induces methylation of both host and viral DNA. / Journal of Virology, / 84, 4321-329. CrossRef
  32. Stresemann, C., & Lyko, F. (2008). Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. / International Journal of Cancer, / 123, 8-3. CrossRef
  33. Hagemann, S., Heil, O., Lyko, F., & Brueckner, B. (2011). Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. / PLoS ONE, / 6, e17388. CrossRef
  34. Ferguson, L. R., Tatham, A. L., Lin, Z., & Denny, W. A. (2011). Epigenetic regulation of gene expression as an anticancer drug target. / Current Cancer Drug Targets, / 11, 199-12. CrossRef
  35. Fraczek, J. E., Vinken, M., Tourwe, D., Vanhaecke, T., & Rogiers, V. (2011). Synergetic effects of DNA demethylation and histone deacetylase inhibition in primary rat hepatocytes. / Investigational New Drugs, / 30(4), 1715-724. CrossRef
  
• 作者单位：Changsong Zhang (1) (2) (3)
  Lieying Fan (2)
  Tingting Fan (2)
  Dong Wu (1)
  Lu Gao (1)
  Yang Ling (3)
  Jing Zhu (3)
  Rong Li (1)
  Lixin Wei (1)
  
  1. Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, 225 Changhai Road, Shanghai, 200438, China
  2. Department of Clinical Laboratory, Shanghai East Hospital, Tongji University Medical School, No. 150, Jimo Road, Shanghai, 200120, China
  3. Clinical Oncology Laboratory, Changzhou Tumor Hospital, Soochow University, Huaide Road, Changzhou, 213001, China
  

文摘

To gain insight into the role of peptidylarginine deiminase type 4 (PADI4), we determined the relationship between PADI4 mRNA and global hypomethylation during HBV exposure in hepatocarcinogenesis. We analyzed Line-1 methylation by MSP, and CD133 mRNA by real-time PCR in 74 HCC. The HCC cancer lines (7721, Huh7, and Hep-G2) were treated with 5-Aza-CdR and TSA. PADI4 mRNA were lower in HCC tissues (Mean??Ct?=?1.41) than that in Non-Hcc tissues (Mean??Ct?=?3.10). Expression of PADI4 was elevated in only 20 (27?%) of the 74 HCC patients but decreased in 54 (73?%) of the patients. The declined PADI4 mRNA was significantly associated with Line-1 demethylation in HCC patients. PADI4 mRNA were lower in HCC patients with Line-1 ?MI <?.15 (Mean???Ct?=??.66) than those with Line-1 ?MI?>=??.15 (Mean???Ct?=??.02). The results suggested that HCC showing hypomethylation of Line-1 is considered to be silencing PADI4 mRNA. And the lower PADI4 mRNA was also found in HCC patients with HBV?>=?105 (copy/ml) than those with HBV?<?105 (copy/ml). After treated by 5-Aza-CdR and TSA, we found that PADI4 mRNA induced significantly by TSA in Huh7 and Hep-G2 cells, but not in 7721 cells. Meanwhile, PADI4 mRNA induced by the combination of 5-Aza-CdR and TSA in HCC cells, and it could no effect for exposure to 5-Aza-CdR alone. The results suggested that decreased PADI4 mRNA is associated with global hypomethylation in HCC during HBV exposure.